According to the UKU scale, Akathisia was the most common adverse effects in both groups (37.2% vs 32.3%, the elevated-PRL group vs the normal-PRL group), the other AEs with an incidence of ≥10% included tremor (37.2% vs 27.2%), reduced sleep duration (14.1% vs 14.2%), tension or inner unrest (16.7% vs 12.6%), hyperkinesia (16.7% vs 10.5%), dystonia(16.7% vs 7.8%), and hypokinesia/akinesia(12.8% vs 5.4%), but were almost always mild to moderate. This evidence concerns the gene PRL and Tremor.